---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-001728"
form_type: "8-K"
ticker: "SNWV"
cik: "0001417663"
company_name: "SANUWAVE Health, Inc."
filed_at: "2024-01-10T23:59:59+00:00"
generated_at: "2026-06-07T00:53:23.633611+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# SANUWAVE Q4 preliminary revenue $6.6-6.8M (record), FY 2023 $20.0-20.2M (record)

## Summary
- Q4 2023 preliminary revenue $6.6-6.8M, up 20-24% YoY and >30% vs Q3 2023; new quarterly record.
- FY 2023 preliminary revenue $20.0-20.2M, up 19-20% YoY; record annual revenue.
- UltraMist product line drove growth: Q4 UltraMist revenue up >30% sequentially, ~95% of total revenue.
- Full Q4 and annual results expected to be released in late March 2024 with future guidance.

## SEC filing metadata
- accession: 0001140361-24-001728
- form_type: 8-K
- ticker: SNWV
- cik: 0001417663
- company_name: SANUWAVE Health, Inc.
- filed_at: 2024-01-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417663/000114036124001728/0001140361-24-001728-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417663/000114036124001728/ef20018511_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-001728
- JSON: https://secwatch.observer/filing/0001140361-24-001728.json
- Plain text: https://secwatch.observer/filing/0001140361-24-001728.txt

## Key facts
- Earnings Releases
  SANUWAVE Health, Inc. reported the quarter and fiscal year ended December 31, 2023 results: revenue preliminary revenues of $6.6 million to $6.8 million for the fourth quarter ended December 31, 2023.
  - Period: the quarter and fiscal year ended December 31, 2023
  - Revenue: preliminary revenues of $6.6 million to $6.8 million for the fourth quarter ended December 31, 2023
  - Result: preliminary results
  source text: announced that revenues for the fourth quarter of 2023 are expected to be in the range of $6.6 to $6.8 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417663/000114036124001728/0001140361-24-001728-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.